| 1 |
32767285 | Glucagon and Liver Fat are Downregulated in Response to Very Low-calorie Diet in Patients with Obesity and Type-2 Diabetes. | 2022 Jan |
1 |
| 2 |
33719063 | Vitamin D binding protein/GC-globulin: a novel regulator of alpha cell function and glucagon secretion. | 2022 Mar |
1 |
| 3 |
34460933 | The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction. | 2022 Jan 18 |
2 |
| 4 |
34463768 | Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg). | 2022 Jan 18 |
2 |
| 5 |
34526455 | Glucagon Response to Glucose Challenge in Patients with Idiopathic Postprandial Syndrome. | 2022 Mar 11 |
1 |
| 6 |
34562190 | The stimulatory effects of glucagon on cortisol and GH secretion occur independently from FGF-21. | 2022 Jan |
1 |
| 7 |
34677817 | Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine - Review. | 2022 Jan |
1 |
| 8 |
34713962 | The incretin/glucagon system as a target for pharmacotherapy of obesity. | 2022 Feb |
1 |
| 9 |
34748791 | Peptides in the regulation of glucagon secretion. | 2022 Feb |
2 |
| 10 |
34756122 | Long-term normothermic machine preservation of human livers: what is needed to succeed? | 2022 Feb 1 |
1 |
| 11 |
34857545 | SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes. | 2022 Mar 1 |
1 |
| 12 |
34889083 | A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP-1 dual agonist. | 2022 Mar |
2 |
| 13 |
34916733 | Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension. | 2022 Jan |
2 |
| 14 |
34932984 | Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist. | 2022 Jan 4 |
2 |
| 15 |
34953208 | Identification of a regulatory pathway of L-phenylalanine-induced GLP-1 secretion in the enteroendocrine L cells. | 2022 Jan 15 |
1 |
| 16 |
35054924 | GLP-1a: Going beyond Traditional Use. | 2022 Jan 10 |
2 |
| 17 |
35057557 | Temporal Patterns of Glucagon and Its Relationships with Glucose and Insulin following Ingestion of Different Classes of Macronutrients. | 2022 Jan 16 |
2 |
| 18 |
35064598 | Efficient synthesis of Aib8 -Arg34 -GLP-1 (7-37) by liquid-phase fragment condensation. | 2022 Jan 22 |
2 |
| 19 |
35077932 | Main glucose hepatic fluxes in healthy subjects predicted from a phenomenological-based model. | 2022 Mar |
2 |
| 20 |
35123462 | The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injury. | 2022 Feb 5 |
2 |
| 21 |
35135006 | The Role of D-allulose and Erythritol on the Activity of the Gut Sweet Taste Receptor and Gastrointestinal Satiation Hormone Release in Humans: A Randomized, Controlled Trial. | 2022 May 5 |
2 |
| 22 |
35180937 | Effects of Glucagon-like peptide 1 (GLP-1) analogs in the hippocampus. | 2022 |
2 |
| 23 |
35189258 | Neural control of pancreatic peptide hormone secretion. | 2022 Jun |
1 |
| 24 |
35200091 | Prehospital Intranasal Glucagon for Hypoglycemia. | 2022 Mar 2 |
1 |
| 25 |
35213713 | Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia. | 2022 May 17 |
2 |
| 26 |
35226299 | New practice in semaglutide on type-2 diabetes and obesity: clinical evidence and expectation. | 2022 Feb |
1 |
| 27 |
35228448 | [New drug for type 2 diabetes: introduction of oral Semaglutide (Rybelsus® tablets), an oral GLP-1 receptor agonist]. | 2022 |
2 |
| 28 |
35237171 | Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters. | 2022 |
2 |
| 29 |
35238131 | Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2-hour plasma glucose in individuals without diabetes. | 2022 Jun |
1 |
| 30 |
35245328 | Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls. | 2022 |
2 |
| 31 |
35245797 | Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis. | 2022 Apr |
1 |
| 32 |
35246864 | Glucose and oleic acid mediate cellular alterations in GLP-1-induced insulin-positive differentiating UCBMSCs. | 2022 May |
6 |
| 33 |
35255598 | Homeostatic Regulation of Glucose Metabolism by the Central Nervous System. | 2022 Feb |
2 |
| 34 |
35263748 | Glucagon for Neonatal Hypoglycaemia: Systematic Review and Meta-Analysis. | 2022 |
2 |
| 35 |
35273901 | Repurposing of existing antibiotics for the treatment of diabetes mellitus. | 2022 |
1 |
| 36 |
35319882 | Generation of Potent and Stable GLP-1 Analogues Via "Serine Ligation". | 2022 Apr 15 |
1 |
| 37 |
35353712 | THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacology. | 2022 Apr 21 |
1 |
| 38 |
35370744 | GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events. | 2022 |
1 |
| 39 |
35373587 | More than meets the islet: aligning nutrient and paracrine inputs with hormone secretion in health and disease. | 2022 May 1 |
1 |
| 40 |
35395220 | Effects of ileal glucose infusion on enteropancreatic hormone secretion in humans: relationship to glucose absorption. | 2022 Jun |
3 |
| 41 |
35437937 | Impaired glucose tolerance is associated with enhanced postprandial pancreatic polypeptide secretion. | 2022 May |
1 |
| 42 |
35442800 | The Effect of Diabetes-Associated Variation in TCF7L2 on Postprandial Glucose Metabolism When Glucagon and Insulin Concentrations Are Matched. | 2022 Apr 18 |
1 |
| 43 |
35443376 | A Study of Correlation of Glucagon-Insulin Ratio with Hba1c in Diabetic Patients in a Tertiary Care Hospital. | 2022 Apr |
1 |
| 44 |
35448534 | Modeling the Amino Acid Effect on Glucagon Secretion from Pancreatic Alpha Cells. | 2022 Apr 13 |
1 |
| 45 |
35452190 | Roles of glucose-dependent insulinotropic polypeptide in diet-induced obesity. | 2022 Apr 22 |
4 |
| 46 |
35471922 | "Smart" Composite Microneedle Patch Stabilizes Glucagon and Prevents Nocturnal Hypoglycemia: Experimental Studies and Molecular Dynamics Simulation. | 2022 May 11 |
2 |
| 47 |
35488292 | Impact of Cotadutide drug on patients with type 2 diabetes mellitus: a systematic review and meta-analysis. | 2022 Apr 29 |
1 |
| 48 |
35491519 | Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study. | 2022 May 1 |
1 |
| 49 |
35562186 | Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetes. | 2022 May 12 |
3 |
| 50 |
35569125 | Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty. | 2022 May |
4 |